Stock Price Prediction

NNVC stock is currently trading at $2.08, reflecting a 19.3% drop recently due to weak investor sentiment and lack of significant catalysts. Bulls argue that NanoViricides' NV-387, a Phase 2 antiviral candidate, shows promise in preclinical studies, potentially driving future valuation. However, the stock remains speculative, with limited near-term upside unless clinical progress accelerates.

NNVC stock closed at $1.20 on January 31, 2025, up 12.15% during regular trading but dropped 1.25% post-market. Bears may argue that the recent surge is speculative, given the lack of substantial news or financial improvements. With its low trading volume and volatile history, the stock could face resistance near $1.25 and risk falling back to $1.10.